BridgeBio Pharma, Inc. (BBIO)
USD 29.55
(-3.65%)
USD 29.55
(-3.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -643.2 Million USD | -30.21% |
| 2022 | -493.96 Million USD | 22.73% |
| 2021 | -639.29 Million USD | -32.11% |
| 2020 | -483.92 Million USD | -85.81% |
| 2019 | -260.43 Million USD | -99.19% |
| 2018 | -130.74 Million USD | -327.77% |
| 2017 | -30.56 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -35.21 Million USD | 79.06% |
| 2024 Q2 | -73.45 Million USD | -108.59% |
| 2023 Q3 | -176.99 Million USD | -12.1% |
| 2023 Q1 | -176.84 Million USD | -13.38% |
| 2023 FY | -643.2 Million USD | -30.21% |
| 2023 Q2 | -157.89 Million USD | 10.71% |
| 2023 Q4 | -168.14 Million USD | 5.0% |
| 2022 Q3 | -148.41 Million USD | -350.01% |
| 2022 Q2 | 59.36 Million USD | 124.06% |
| 2022 Q1 | -246.71 Million USD | -67.63% |
| 2022 FY | -493.96 Million USD | 22.73% |
| 2022 Q4 | -155.97 Million USD | -5.09% |
| 2021 FY | -639.29 Million USD | -32.11% |
| 2021 Q3 | -155.93 Million USD | -61.85% |
| 2021 Q1 | -163.07 Million USD | -35.92% |
| 2021 Q2 | -96.34 Million USD | 40.92% |
| 2021 Q4 | -147.17 Million USD | 5.62% |
| 2020 Q4 | -119.98 Million USD | -3.56% |
| 2020 Q2 | -121.03 Million USD | -31.77% |
| 2020 Q1 | -91.85 Million USD | -25.04% |
| 2020 FY | -483.92 Million USD | -85.81% |
| 2020 Q3 | -115.85 Million USD | 4.28% |
| 2019 Q1 | -61.18 Million USD | -58.34% |
| 2019 FY | -260.43 Million USD | -99.19% |
| 2019 Q4 | -73.45 Million USD | -22.47% |
| 2019 Q3 | -59.98 Million USD | 8.98% |
| 2019 Q2 | -65.89 Million USD | -7.7% |
| 2018 Q3 | -31.4 Million USD | -18.27% |
| 2018 Q4 | -38.64 Million USD | -23.06% |
| 2018 Q1 | -34.15 Million USD | 0.0% |
| 2018 FY | -130.74 Million USD | -327.77% |
| 2018 Q2 | -26.55 Million USD | 22.27% |
| 2017 FY | -30.56 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -46.102% |
| AlloVir, Inc. | -190.41 Million USD | -237.784% |
| Aptorum Group Limited | -2.82 Million USD | -22671.058% |
| Ardelyx, Inc. | -66.06 Million USD | -873.56% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -213.337% |
| Bicycle Therapeutics plc | -180.66 Million USD | -256.021% |
| AbCellera Biologics Inc. | -146.39 Million USD | -339.352% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -259.224% |
| Chimerix, Inc. | -82.09 Million USD | -683.485% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1342.05% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1307.321% |
| Alkermes plc | 355.75 Million USD | 280.798% |
| Fortress Biotech, Inc. | -60.63 Million USD | -960.742% |
| Fortress Biotech, Inc. | -60.63 Million USD | -960.742% |
| Agenus Inc. | -245.76 Million USD | -161.718% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -688.431% |
| Dyadic International, Inc. | -6.79 Million USD | -9365.171% |
| ImmuCell Corporation | -5.77 Million USD | -11038.472% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -68618.162% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -469.402% |
| Lantern Pharma Inc. | -15.96 Million USD | -3929.7% |
| Immix Biopharma, Inc. | -15.42 Million USD | -4069.584% |
| Incyte Corporation | 597.59 Million USD | 207.631% |
| IO Biotech, Inc. | -86.08 Million USD | -647.188% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -1003.395% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -3280.135% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -990.493% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -290.828% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -320.415% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -7466.192% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -1081.879% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1333.275% |
| ContextLogic Inc. | -317 Million USD | -102.903% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -776.93% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -72.149% |
| MiMedx Group, Inc. | 67.43 Million USD | 1053.754% |
| MEI Pharma, Inc. | 17.77 Million USD | 3717.966% |
| Novavax, Inc. | -545.06 Million USD | -18.005% |
| NextCure, Inc. | -62.72 Million USD | -925.464% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -6341.037% |
| Onconetix, Inc. | -37.4 Million USD | -1619.346% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1529.226% |
| Opthea Limited | -220.24 Million USD | -192.043% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1157.26% |
| Vaxcyte, Inc. | -402.26 Million USD | -59.895% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1397.832% |
| Precigen, Inc. | -95.9 Million USD | -570.673% |
| Pharming Group N.V. | -10.54 Million USD | -5997.857% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -219.061% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2520.715% |
| PureTech Health plc | -65.69 Million USD | -879.043% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -771.666% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2463.477% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -203.083% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -3368.126% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2542.649% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2542.649% |
| Seer, Inc. | -86.27 Million USD | -645.508% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -149.467% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2261.414% |
| Acelyrin, Inc. | -381.64 Million USD | -68.536% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -5128002.504% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1622.555% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1786.168% |
| Senti Biosciences, Inc. | -92.91 Million USD | -592.218% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1879.997% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -514.334% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1730.398% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4820.507% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -9521.571% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -2090.593% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -2160.657% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -3069.888% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -1018.359% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -933.173% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -385.461% |
| ChromaDex Corporation | -4.93 Million USD | -12925.557% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -12.282% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -17826.477% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1159.748% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -530.158% |
| CRISPR Therapeutics AG | -153.61 Million USD | -318.724% |
| Precision BioSciences, Inc. | -61.31 Million USD | -948.944% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -299.683% |
| Innoviva, Inc. | 179.72 Million USD | 457.887% |
| Jaguar Health, Inc. | -41.3 Million USD | -1457.39% |
| Summit Therapeutics Inc. | -614.92 Million USD | -4.598% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -860.075% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -878.031% |
| ESSA Pharma Inc. | -26.58 Million USD | -2319.659% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1643.122% |
| GT Biopharma, Inc. | -7.59 Million USD | -8366.526% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -166.49% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1138.714% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 1000.717% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1209.45% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -6365.806% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -161.895% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1156.082% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -554.339% |
| Soligenix, Inc. | -6.14 Million USD | -10374.357% |
| Century Therapeutics, Inc. | -136.67 Million USD | -370.614% |
| Kura Oncology, Inc. | -152.63 Million USD | -321.41% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -620.933% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -6003.644% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 113846.441% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -112940.773% |
| Autolus Therapeutics plc | -208.38 Million USD | -208.663% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -794.603% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -808.542% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2868.442% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -185.55% |
| GRI Bio, Inc. | -13.03 Million USD | -4833.666% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -15456.654% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -418.36% |
| IGM Biosciences, Inc. | -246.41 Million USD | -161.023% |
| INmune Bio, Inc. | -30 Million USD | -2043.435% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -481.773% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1424.4% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3929.669% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3972.192% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -977.661% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -535.782% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -132.938% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -170.376% |
| Verastem, Inc. | -87.36 Million USD | -636.207% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -1086.982% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -298.672% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -451.357% |
| Histogen Inc. | -10.62 Million USD | -5955.946% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -4402.086% |
| Surrozen, Inc. | -43.04 Million USD | -1394.359% |
| Organovo Holdings, Inc. | -14.67 Million USD | -4284.173% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -12543.962% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1128.916% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2446.024% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2287.713% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -7596.487% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -325.722% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1214.641% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -2063.842% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -6074.124% |
| Apollomics, Inc. | -172.6 Million USD | -272.653% |
| Amarin Corporation plc | -59.11 Million USD | -988.107% |
| Mesoblast Limited | -87.95 Million USD | -631.277% |
| Turnstone Biologics Corp. | -55.2 Million USD | -1065.221% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -337.666% |
| Synaptogenix, Inc. | -6.03 Million USD | -10551.678% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3868.423% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -724.407% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -13323.908% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -7555.165% |
| Exelixis, Inc. | 207.76 Million USD | 409.581% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1517.711% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -346.829% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -21.674% |
| NLS Pharmaceutics AG | -12.17 Million USD | -5184.263% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -8151.797% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1991.782% |
| Gritstone bio, Inc. | -138.49 Million USD | -364.439% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -897.754% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -15980.251% |
| Avid Bioservices, Inc. | -140.75 Million USD | -356.972% |
| Insmed Incorporated | -749.56 Million USD | 14.19% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -4134.515% |
| MediWound Ltd. | -6.71 Million USD | -9477.159% |
| OmniAb, Inc. | -50.61 Million USD | -1170.673% |
| Alector, Inc. | -130.39 Million USD | -393.287% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -465.582% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1140.577% |
| Zai Lab Limited | -334.62 Million USD | -92.219% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -98.528% |
| Aura Biosciences, Inc. | -76.4 Million USD | -741.799% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -174.132% |
| Immunic, Inc. | -93.61 Million USD | -587.094% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -373.315% |
| Veracyte, Inc. | -74.4 Million USD | -764.472% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -8279.882% |
| FibroGen, Inc. | -284.23 Million USD | -126.295% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2351.975% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -9086.12% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -3315.348% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 255.051% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2751.705% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1405.437% |
| TG Therapeutics, Inc. | 12.67 Million USD | 5175.773% |
| Galecto, Inc. | -38.34 Million USD | -1577.233% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -3309.318% |
| Fortrea Holdings Inc. | -3.4 Million USD | -18817.706% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -407.882% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3594.228% |
| XBiotech Inc. | -24.55 Million USD | -2519.221% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -897.754% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -926.168% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -553.488% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2901.829% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -1065.369% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -6.027% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -842.351% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1129632.673% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -183.926% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2788.521% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -192.75% |
| NexImmune, Inc. | -32.34 Million USD | -1888.604% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -12066.708% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -4479.288% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 116.269% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2555.555% |
| Scopus BioPharma Inc. | -11.6 Million USD | -5440.151% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -450.696% |
| Ainos, Inc. | -13.77 Million USD | -4570.852% |
| Pluri Inc. | -20.88 Million USD | -2979.29% |
| Prothena Corporation plc | -147.02 Million USD | -337.469% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -464.851% |
| Celularity Inc. | -196.29 Million USD | -227.671% |
| Rallybio Corporation | -74.56 Million USD | -762.617% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1167.818% |
| MeiraGTx Holdings plc | -84.02 Million USD | -665.471% |
| Omeros Corporation | -117.81 Million USD | -445.952% |
| Humacyte, Inc. | -110.77 Million USD | -480.633% |
| Immunocore Holdings plc | -55.28 Million USD | -1063.387% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -3476.524% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2704.945% |
| Blueprint Medicines Corporation | -506.98 Million USD | -26.868% |
| CalciMedica, Inc. | -34.35 Million USD | -1772.113% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -850.428% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -354.865% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -287.964% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -127.075% |
| Pulmatrix, Inc. | -14.12 Million USD | -4454.932% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1727.538% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -678.337% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -33.668% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -513.327% |
| Cytokinetics, Incorporated | -526.24 Million USD | -22.225% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1683.452% |
| Nutriband Inc. | -5.48 Million USD | -11625.892% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1491.296% |
| Vor Biopharma Inc. | -117.86 Million USD | -445.72% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 114.79% |
| Evogene Ltd. | -23.87 Million USD | -2593.589% |
| ProKidney Corp. | -35.46 Million USD | -1713.471% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -437.062% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -8098.471% |
| CorMedix Inc. | -46.33 Million USD | -1288.029% |
| BioLineRx Ltd. | -60.61 Million USD | -961.144% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -532.177% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1466.264% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1499.05% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -697.521% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -751.686% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -120.131% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -2207.368% |
| MediciNova, Inc. | -8.57 Million USD | -7403.947% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -421.753% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7578.342% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2377.02% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -168.854% |
| Biomea Fusion, Inc. | -117.25 Million USD | -448.55% |
| PTC Therapeutics, Inc. | -626.6 Million USD | -2.649% |
| Mereo BioPharma Group plc | -29.46 Million USD | -2082.862% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -319.949% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -207.223% |
| Absci Corporation | -110.56 Million USD | -481.736% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -2033.34% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -537.863% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -172.616% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 4666.899% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -233.331% |
| Allakos Inc. | -185.7 Million USD | -246.364% |
| Imunon, Inc. | -19.51 Million USD | -3195.94% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -560.813% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 705.994% |
| BioAtla, Inc. | -123.46 Million USD | -420.972% |
| NLS Pharmaceutics AG | -12.17 Million USD | -5184.263% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3900.51% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -96.539% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1640.783% |
| XOMA Corporation | -40.83 Million USD | -1475.279% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -531.395% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -442.727% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1176.473% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -633.587% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -323.831% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -170.555% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1731.493% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -7848.675% |
| Akari Therapeutics, Plc | -10 Million USD | -6326.878% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -955268.734% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 328.415% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9550.589% |
| UroGen Pharma Ltd. | -102.24 Million USD | -529.085% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -502.289% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -8170.371% |
| Orgenesis Inc. | -55.36 Million USD | -1061.832% |
| Entera Bio Ltd. | -8.88 Million USD | -7135.932% |
| GH Research PLC | -35.58 Million USD | -1707.407% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2986.382% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -731.139% |
| Xencor, Inc. | -126.08 Million USD | -410.126% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -16980.534% |
| Replimune Group, Inc. | -215.79 Million USD | -198.063% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2924.479% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 25735.791% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9550.589% |
| Portage Biotech Inc. | -75.33 Million USD | -753.744% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7578.342% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -565.462% |
| OncoCyte Corporation | -27.78 Million USD | -2215.259% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -4693.857% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -5683.4% |
| Purple Biotech Ltd. | -19.88 Million USD | -3135.423% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -9063.727% |
| scPharmaceuticals Inc. | -54.81 Million USD | -1073.512% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3574.15% |
| HilleVax, Inc. | -123.56 Million USD | -420.533% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -6263.926% |
| Tharimmune, Inc. | -9.31 Million USD | -6801.98% |
| Genprex, Inc. | -30.86 Million USD | -1984.227% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -172.63% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -2037.31% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -35994.388% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -12045.018% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3822689.986% |
| Savara Inc. | -54.69 Million USD | -1075.915% |
| Curis, Inc. | -47.41 Million USD | -1256.594% |
| Daré Bioscience, Inc. | -30.16 Million USD | -2032.534% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -4064.444% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -11449.686% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -2057.31% |
| BeiGene, Ltd. | -881.7 Million USD | 27.05% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2920.579% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -47.399% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -714.644% |
| Erasca, Inc. | -125.04 Million USD | -414.389% |
| bluebird bio, Inc. | -211.91 Million USD | -203.522% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12762.761% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 483.669% |
| DBV Technologies S.A. | -72.72 Million USD | -784.418% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12762.761% |
| Moderna, Inc. | -4.71 Billion USD | 86.355% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1501.718% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -11196.136% |
| Molecular Templates, Inc. | -8.12 Million USD | -7817.307% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -965.116% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -477.386% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -375.207% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1242.269% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -354.788% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -234.287% |
| MacroGenics, Inc. | -9.05 Million USD | -7000.927% |
| RenovoRx, Inc. | -10.23 Million USD | -6186.181% |
| Adicet Bio, Inc. | -142.65 Million USD | -350.87% |
| Prime Medicine, Inc. | -198.13 Million USD | -224.631% |
| Aditxt, Inc. | -32.38 Million USD | -1886.366% |
| Adagene Inc. | -18.94 Million USD | -3294.856% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8696.86% |
| Quantum-Si incorporated | -95.96 Million USD | -570.281% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -440.374% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4312.212% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 586.059% |
| SciSparc Ltd. | -5.12 Million USD | -12457.634% |
| Vericel Corporation | -3.18 Million USD | -20113.765% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -534769.526% |
| Minerva Neurosciences, Inc. | -30 Million USD | -2043.624% |
| Generation Bio Co. | -126.61 Million USD | -408.01% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -782.416% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -680.187% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -145.366% |
| Invivyd, Inc. | -198.64 Million USD | -223.798% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -88.086% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -7304.554% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2920.319% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -6414.098% |
| 2seventy bio, Inc. | -217.57 Million USD | -195.63% |
| ADMA Biologics, Inc. | -28.23 Million USD | -2177.708% |
| Clene Inc. | -49.5 Million USD | -1199.293% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2785.926% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1201.133% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2377.02% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -96.059% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1876.473% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2930.995% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -551.069% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -760.425% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -299.989% |
| Vir Biotechnology, Inc. | -615.06 Million USD | -4.575% |
| Evaxion Biotech A/S | -22.12 Million USD | -2807.128% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -696.673% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -221.492% |
| Trevena, Inc. | -40.28 Million USD | -1496.471% |
| Surrozen, Inc. | -43.04 Million USD | -1394.359% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -830.37% |
| Cingulate Inc. | -23.53 Million USD | -2632.966% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -9205.584% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1513.653% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -8241.71% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -613.005% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -949.509% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -980.957% |
| Clearmind Medicine Inc. | -11.95 Million USD | -5280.178% |
| Kronos Bio, Inc. | -112.67 Million USD | -470.857% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -829.523% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -25360454.839% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -648.824% |
| Statera Biopharma, Inc. | -174.4 Million USD | -268.791% |
| ImmunityBio, Inc. | -583.19 Million USD | -10.289% |
| Korro Bio, Inc. | -81.17 Million USD | -692.394% |
| Kineta, Inc. | -14.09 Million USD | -4462.04% |
| BioVie Inc. | -32.12 Million USD | -1902.464% |
| Codexis, Inc. | -76.24 Million USD | -743.654% |
| Celularity Inc. | -196.29 Million USD | -227.671% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -199.821% |
| Celcuity Inc. | -63.77 Million USD | -908.484% |
| Virax Biolabs Group Limited | -6.73 Million USD | -9452.216% |
| Cibus, Inc. | -267.62 Million USD | -140.335% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1495.006% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1696.102% |
| IN8bio, Inc. | -30 Million USD | -2043.507% |
| Kodiak Sciences Inc. | -260.49 Million USD | -146.919% |
| Annexon, Inc. | -134.23 Million USD | -379.154% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -448.971% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -950.503% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1939.063% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -75.601% |
| Eyenovia, Inc. | -27.26 Million USD | -2259.414% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 3079.028% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -120124.673% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -741.843% |
| Arcellx, Inc. | -70.69 Million USD | -809.891% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1452.091% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -380.662% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -2041.366% |
| Moolec Science SA | -51.78 Million USD | -1141.969% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1128.164% |
| Geron Corporation | -184.12 Million USD | -249.325% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1432.382% |
| Royalty Pharma plc | 1.13 Billion USD | 156.678% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -373.096% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -7133.651% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2927.797% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -274.674% |
| Humacyte, Inc. | -110.77 Million USD | -480.633% |
| Structure Therapeutics Inc. | -89.62 Million USD | -617.699% |
| 89bio, Inc. | -142.18 Million USD | -352.357% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -832.718% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -6098.342% |
| Genelux Corporation | -28.29 Million USD | -2173.04% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -2112.978% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -263.147% |
| Notable Labs, Ltd. | -11.26 Million USD | -5610.245% |
| Liquidia Corporation | -78.5 Million USD | -719.345% |
| Mustang Bio, Inc. | -51.6 Million USD | -1146.467% |
| Immunovant, Inc. | -259.33 Million USD | -148.019% |
| Quantum-Si incorporated | -95.96 Million USD | -570.281% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -782.925% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -3218.725% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -570.072% |
| Acasti Pharma Inc. | -12.85 Million USD | -4904.295% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2764.04% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3929.669% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -252.646% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -14852.911% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -5057.995% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -2081.011% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1549.744% |
| PepGen Inc. | -78.62 Million USD | -718.053% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -2060.644% |
| United Therapeutics Corporation | 984.8 Million USD | 165.313% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2789.497% |
| Solid Biosciences Inc. | -96.01 Million USD | -569.897% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -13323.908% |
| Immuneering Corporation | -53.47 Million USD | -1102.885% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -12543.962% |
| Silo Pharma, Inc. | -3.7 Million USD | -17280.629% |
| Belite Bio, Inc | -31.63 Million USD | -1933.39% |
| XOMA Corporation | -40.83 Million USD | -1475.279% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -1083.118% |
| Bionomics Limited | -15.49 Billion USD | 95.848% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -665.853% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2105.995% |
| uniQure N.V. | -308.47 Million USD | -108.508% |
| Cassava Sciences, Inc. | -97.21 Million USD | -561.615% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8696.86% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -421.107% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1943.468% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -7742.298% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -2112.749% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -120124.673% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2351.975% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3801.741% |
| Altimmune, Inc. | -88.44 Million USD | -627.217% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -324.321% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2105.995% |
| Compugen Ltd. | -18.75 Million USD | -3329.679% |
| Peak Bio, Inc. | -1259.26 USD | -51077675.837% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1296.777% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2857.115% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -89.853% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -675.372% |
| Zura Bio Limited | -60.36 Million USD | -965.61% |
| PolyPid Ltd. | -23.86 Million USD | -2595.169% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3988.495% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -675.372% |
| Instil Bio, Inc. | -156.08 Million USD | -312.079% |
| argenx SE | -295.05 Million USD | -117.995% |
| Immunome, Inc. | -106.8 Million USD | -502.215% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1413.63% |
| Verona Pharma plc | -54.36 Million USD | -1083.031% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -543.736% |
| Shattuck Labs, Inc. | -87.29 Million USD | -636.789% |
| CervoMed Inc. | -2.17 Million USD | -29515.083% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -416.002% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -4730.294% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1376.758% |
| Moolec Science SA | -51.78 Million USD | -1141.969% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3719608.786% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -376.032% |
| AnaptysBio, Inc. | -163.61 Million USD | -293.11% |
| Design Therapeutics, Inc. | -66.86 Million USD | -861.984% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -690.039% |
| NeurAxis, Inc. | -14.62 Million USD | -4297.456% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1597.909% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1789.881% |
| Achilles Therapeutics plc | -69.66 Million USD | -823.279% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -543.736% |
| 180 Life Sciences Corp. | -19.93 Million USD | -3126.478% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 21477.431% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -25360454.839% |
| Nutriband Inc. | -5.48 Million USD | -11625.892% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -538.75% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1223.27% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -734.341% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1793.441% |
| MoonLake Immunotherapeutics | -36 Million USD | -1686.312% |
| Palisade Bio, Inc. | -12.3 Million USD | -5129.285% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1426.925% |
| Beam Therapeutics Inc. | -132.52 Million USD | -385.337% |
| Neurogene Inc. | -36.31 Million USD | -1671.077% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -293.6% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1123.841% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -555.346% |
| Sesen Bio, Inc. | -19.88 Million USD | -3134.772% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -798.528% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -5039.902% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -44.853% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -476.522% |
| Athira Pharma, Inc. | -117.67 Million USD | -446.606% |
| Vaccinex, Inc. | -20.25 Million USD | -3076.149% |
| HCW Biologics Inc. | -24.99 Million USD | -2473.397% |
| XOMA Corporation | -40.83 Million USD | -1475.279% |
| Nektar Therapeutics | -276.05 Million USD | -132.997% |
| Arvinas, Inc. | -367.3 Million USD | -75.116% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -955268.734% |
| Merus N.V. | -154.93 Million USD | -315.132% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -560.182% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1949.393% |
| Rezolute, Inc. | -68.45 Million USD | -839.543% |
| Clene Inc. | -49.5 Million USD | -1199.293% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -4070.28% |
| BeyondSpring Inc. | -21.02 Million USD | -2959.079% |
| Synlogic, Inc. | -57.28 Million USD | -1022.869% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -5304.605% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5841.271% |
| Peak Bio, Inc. | -1259.26 USD | -51077675.837% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1621.264% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5983.663% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -349.48% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -97.845% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -13825.241% |
| MannKind Corporation | -11.93 Million USD | -5287.854% |
| Ikena Oncology, Inc. | -68.16 Million USD | -843.582% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2960.68% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -592.114% |
| Gossamer Bio, Inc. | -179.81 Million USD | -257.698% |
| CohBar, Inc. | -11.96 Million USD | -5276.99% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2394.191% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -2033.34% |
| Legend Biotech Corporation | -518.25 Million USD | -24.109% |
| Mural Oncology plc | -207.44 Million USD | -210.056% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -418.231% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3416.74% |
| Disc Medicine, Inc. | -76.42 Million USD | -741.568% |
| Champions Oncology, Inc. | -7.27 Million USD | -8740.049% |
| REGENXBIO Inc. | -263.49 Million USD | -144.105% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5960.468% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1253.967% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1593.372% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -542.155% |
| Vaxart, Inc. | -82.46 Million USD | -679.97% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 192812.194% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1613.263% |
| Cellectis S.A. | -101.05 Million USD | -536.462% |
| Longeveron Inc. | -21.41 Million USD | -2903.792% |
| Repare Therapeutics Inc. | -93.79 Million USD | -585.746% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -20.006% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -803.767% |
| Revolution Medicines, Inc. | -436.36 Million USD | -47.399% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -9688.495% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1986.692% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -827.7% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -893.638% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -6455.927% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 117.77% |
| Denali Therapeutics Inc. | -145.22 Million USD | -342.903% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -534769.526% |
| Veru Inc. | -93.15 Million USD | -590.481% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2279.674% |
| Cingulate Inc. | -23.53 Million USD | -2632.966% |
| Passage Bio, Inc. | -102.06 Million USD | -530.207% |
| Context Therapeutics Inc. | -23.96 Million USD | -2584.011% |
| Exicure, Inc. | -16.91 Million USD | -3702.779% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -240.468% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1603.215% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -9784.277% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -248.283% |
| Nuvalent, Inc. | -126.21 Million USD | -409.592% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -6016.613% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -640.342% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -2005.821% |
| OmniAb, Inc. | -50.61 Million USD | -1170.673% |
| Anew Medical, Inc. | 1.34 Million USD | 47881.744% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3908.738% |
| Lipocine Inc. | -16.35 Million USD | -3833.456% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -868.765% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -910.133% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1424.4% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1240.926% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -3143.417% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -18.784% |
| Ocugen, Inc. | -63.07 Million USD | -919.693% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -571.878% |
| Q32 Bio Inc. | -112.96 Million USD | -469.402% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3641.287% |
| Alumis Inc. Common Stock | -154.99 Million USD | -314.988% |
| Equillium, Inc. | -13.33 Million USD | -4723.412% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -965.504% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -7952.268% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -3311.99% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -988.66% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -461.616% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3399.856% |
| Dominari Holdings Inc. | -22.88 Million USD | -2710.952% |
| Edesa Biotech, Inc. | -8.37 Million USD | -7580.56% |
| vTv Therapeutics Inc. | -20.25 Million USD | -3076.306% |
| Bio-Techne Corporation | 168.1 Million USD | 482.619% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -82.682% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 599.175% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -427.942% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1595.358% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -471.014% |
| Nkarta, Inc. | -117.5 Million USD | -447.401% |
| BioCardia, Inc. | -11.57 Million USD | -5458.742% |
| Iterum Therapeutics plc | -38.37 Million USD | -1576.271% |